Our analysis of a cohort of 362 lung cancer patients, including 151 LUSC patients, revealed that the MYO10 mRNA expression ratio between tumor and adjacent tumor-free tissues is an independent prognostic factor that is associated with poor overall survival in patients with resected LUSC. This evidence concerns the gene MYO10 and lung cancer.